{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:23:08Z","timestamp":1789050188928,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Provincial Public Welfare Technology Application Research Projects under gran","award":["LGF18H030008"],"award-info":[{"award-number":["LGF18H030008"]}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project under grant","award":["2018KY836"],"award-info":[{"award-number":["2018KY836"]}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project under grant","award":["2018RC077"],"award-info":[{"award-number":["2018RC077"]}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project under grant","award":["2020RC127"],"award-info":[{"award-number":["2020RC127"]}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Project under grant","award":["2019ZD057"],"award-info":[{"award-number":["2019ZD057"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China under grant","award":["LY19H160016"],"award-info":[{"award-number":["LY19H160016"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602044"],"award-info":[{"award-number":["81602044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gallbladder cancer is the most common malignant tumor of the biliary system and is characterized by difficulty to diagnose in early stages, a high degree of malignancy, and poor prognosis. Finding new drugs may improve the prognosis for this dismal cancer. Herein, we investigated the potential application of pterostilbene (PTS) against gallbladder cancer in vivo and in vitro. PTS potently inhibited cell proliferation, migration and invasion of gallbladder cancer cells. Moreover, PTS also had a function of inducing apoptosis in vitro. Meanwhile, PTS reversed EMT with a correlated inhibition of PI3K\/Akt activation. Tumor xenograft models showed that PTS inhibited tumor growth and had low toxicity in vivo<jats:italic>,<\/jats:italic> which were consistent with the in vitro data. These findings indicate that PTS arrests cell growth through inhibition of PI3K\/AKT signaling and is a potential drug for the therapy of gallbladder cancer.<\/jats:p>","DOI":"10.1038\/s41598-021-83924-4","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T11:05:33Z","timestamp":1614078333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K\/Akt pathway"],"prefix":"10.1038","volume":"11","author":[{"given":"Chenhao","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenda","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"issue":"7","key":"83924_CR1","doi-asserted-by":"publisher","first-page":"vii345","DOI":"10.1093\/annonc\/mdq420","volume":"21","author":"JW Valle","year":"2010","unstructured":"Valle, J. W. Advances in the treatment of metastatic or unresectable biliary tract cancer. Ann.. Oncol. 21(7), vii345\u2013vii348. https:\/\/doi.org\/10.1093\/annonc\/mdq420 (2010).","journal-title":"Ann.. Oncol."},{"key":"83924_CR2","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma, A., Sharma, K. L., Gupta, A., Yadav, A. & Kumar, A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J. Gastroenterol. 23, 3978\u20133998. https:\/\/doi.org\/10.3748\/wjg.v23.i22.3978 (2017).","journal-title":"World J. Gastroenterol."},{"key":"83924_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CLEP.S37357","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal, R. & Shaffer, E. A. Gallbladder cancer: epidemiology and outcome. Clin. Epidemiol. 6, 99\u2013109. https:\/\/doi.org\/10.2147\/CLEP.S37357 (2014).","journal-title":"Clin. Epidemiol."},{"key":"83924_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1245\/s10434-009-0538-x","volume":"16","author":"MT Hueman","year":"2009","unstructured":"Hueman, M. T., Vollmer, C. M. Jr. & Pawlik, T. M. Evolving treatment strategies for gallbladder cancer. Ann. Surg. Oncol. 16, 2101\u20132115. https:\/\/doi.org\/10.1245\/s10434-009-0538-x (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"83924_CR5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3760\/cma.j.issn.0253-3766.2018.12.004","volume":"40","author":"JY Tuo","year":"2018","unstructured":"Tuo, J. Y. et al. Report of incidence and mortality of gallbladder cancer in China, 2014. Zhonghua Zhong Liu Za Zhi 40, 894\u2013899. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2018.12.004 (2018).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"83924_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J. Clin. Oncol. 31, 1188\u20131195. https:\/\/doi.org\/10.1200\/JCO.2012.41.5984 (2013).","journal-title":"J. Clin. Oncol."},{"key":"83924_CR7","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","volume":"29","author":"SJ Wang","year":"2011","unstructured":"Wang, S. J. et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J. Clin. Oncol. 29, 4627\u20134632. https:\/\/doi.org\/10.1200\/JCO.2010.33.8020 (2011).","journal-title":"J. Clin. Oncol."},{"key":"83924_CR8","doi-asserted-by":"publisher","first-page":"CD011746","DOI":"10.1002\/14651858.CD011746.pub2","volume":"4","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman, O., Elsayed, Z. & Elhalawani, H. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database Syst. Rev. 4, CD011746. https:\/\/doi.org\/10.1002\/14651858.CD011746.pub2 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"83924_CR9","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.ejca.2014.08.013","volume":"50","author":"JM Phelip","year":"2014","unstructured":"Phelip, J. M. et al. Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: federation Francophone de Cancerologie Digestive 9902 phase II randomised study. Eur. J. Cancer 50, 2975\u20132982. https:\/\/doi.org\/10.1016\/j.ejca.2014.08.013 (2014).","journal-title":"Eur. J. Cancer"},{"key":"83924_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362, 1273\u20131281. https:\/\/doi.org\/10.1056\/NEJMoa0908721 (2010).","journal-title":"N Engl J Med"},{"key":"83924_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/cncr.30968","volume":"124","author":"HS Tran Cao","year":"2018","unstructured":"Tran Cao, H. S. et al. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer 124, 74\u201383. https:\/\/doi.org\/10.1002\/cncr.30968 (2018).","journal-title":"Cancer"},{"key":"83924_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2016.07.046","volume":"789","author":"R Kosuru","year":"2016","unstructured":"Kosuru, R., Rai, U., Prakash, S., Singh, A. & Singh, S. Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence. Eur. J. Pharmacol. 789, 229\u2013243. https:\/\/doi.org\/10.1016\/j.ejphar.2016.07.046 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"83924_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jfda.2016.07.004","volume":"25","author":"HY Tsai","year":"2017","unstructured":"Tsai, H. Y., Ho, C. T. & Chen, Y. K. Biological actions and molecular effects of resveratrol, pterostilbene, and 3\u2019-hydroxypterostilbene. J. Food. Drug Anal. 25, 134\u2013147. https:\/\/doi.org\/10.1016\/j.jfda.2016.07.004 (2017).","journal-title":"J. Food. Drug Anal."},{"key":"83924_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.biopha.2017.07.075","volume":"94","author":"MA Sayeed","year":"2017","unstructured":"Sayeed, M. A. et al. Regulation of microRNA using promising dietary phytochemicals: possible preventive and treatment option of malignant mesothelioma. Biomed. Pharmacother. 94, 1197\u20131224. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.075 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"83924_CR15","doi-asserted-by":"publisher","first-page":"e0162335","DOI":"10.1371\/journal.pone.0162335","volume":"11","author":"H Lee","year":"2016","unstructured":"Lee, H., Kim, Y., Jeong, J. H., Ryu, J. H. & Kim, W. Y. ATM\/CHK\/p53 pathway dependent chemopreventive and therapeutic activity on lung cancer by pterostilbene. PLoS ONE 11, e0162335. https:\/\/doi.org\/10.1371\/journal.pone.0162335 (2016).","journal-title":"PLoS ONE"},{"key":"83924_CR16","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1038\/s41598-017-08547-0","volume":"7","author":"Z Ma","year":"2017","unstructured":"Ma, Z. et al. Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress. Sci. Rep. 7, 8091. https:\/\/doi.org\/10.1038\/s41598-017-08547-0 (2017).","journal-title":"Sci. Rep."},{"key":"83924_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tiv.2017.06.004","volume":"43","author":"M Zielinska-Przyjemska","year":"2017","unstructured":"Zielinska-Przyjemska, M., Kaczmarek, M., Krajka-Kuzniak, V., Luczak, M. & Baer-Dubowska, W. The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines. Toxicol. In Vitro 43, 69\u201375. https:\/\/doi.org\/10.1016\/j.tiv.2017.06.004 (2017).","journal-title":"Toxicol. In Vitro"},{"key":"83924_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1159\/000443071","volume":"38","author":"Y Feng","year":"2016","unstructured":"Feng, Y. et al. Pterostilbene inhibits the growth of human esophageal cancer cells by regulating endoplasmic reticulum stress. Cell Physiol. Biochem. 38, 1226\u20131244. https:\/\/doi.org\/10.1159\/000443071 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"83924_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-017-0441-z","volume":"10","author":"YJ Wang","year":"2017","unstructured":"Wang, Y. J. et al. Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis. J. Hematol. Oncol. 10, 72. https:\/\/doi.org\/10.1186\/s13045-017-0441-z (2017).","journal-title":"J. Hematol. Oncol."},{"key":"83924_CR20","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/mnfr.201000067","volume":"54","author":"RJ Chen","year":"2010","unstructured":"Chen, R. J., Ho, C. T. & Wang, Y. J. Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol. Nutr. Food Res. 54, 1819\u20131832. https:\/\/doi.org\/10.1002\/mnfr.201000067 (2010).","journal-title":"Mol. Nutr. Food Res."},{"key":"83924_CR21","doi-asserted-by":"publisher","first-page":"37417","DOI":"10.1038\/srep37417","volume":"6","author":"Y Kong","year":"2016","unstructured":"Kong, Y. et al. Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci. Rep. 6, 37417. https:\/\/doi.org\/10.1038\/srep37417 (2016).","journal-title":"Sci. Rep."},{"key":"83924_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.oraloncology.2015.03.007","volume":"51","author":"CP Ko","year":"2015","unstructured":"Ko, C. P. et al. Pterostilbene induce autophagy on human oral cancer cells through modulation of Akt and mitogen-activated protein kinase pathway. Oral. Oncol. 51, 593\u2013601. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.03.007 (2015).","journal-title":"Oral. Oncol."},{"key":"83924_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"83924_CR24","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1158\/1535-7163.MCT-16-0391","volume":"15","author":"X Dai","year":"2016","unstructured":"Dai, X. et al. Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma. Mol. Cancer Ther. 15, 2966\u20132976. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0391 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"83924_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.tips.2016.04.006","volume":"37","author":"N Syn","year":"2016","unstructured":"Syn, N., Wang, L., Sethi, G., Thiery, J. P. & Goh, B. C. Exosome-mediated metastasis: from epithelial-mesenchymal transition to escape from immunosurveillance. Trends Pharmacol. Sci. 37, 606\u2013617. https:\/\/doi.org\/10.1016\/j.tips.2016.04.006 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"83924_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jhep.2013.04.034","volume":"59","author":"Y Chang","year":"2013","unstructured":"Chang, Y. et al. MiR-20a triggers metastasis of gallbladder carcinoma. J. Hepatol. 59, 518\u2013527. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.034 (2013).","journal-title":"J. Hepatol."},{"key":"83924_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2019.03.003","volume":"59","author":"T Ijuin","year":"2019","unstructured":"Ijuin, T. Phosphoinositide phosphatases in cancer cell dynamics-Beyond PI3K and PTEN. Semin. Cancer Biol. 59, 50\u201365. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.003 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"83924_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman, D. A. et al. The PI3K pathway in human disease. Cell 170, 605\u2013635. https:\/\/doi.org\/10.1016\/j.cell.2017.07.029 (2017).","journal-title":"Cell"},{"key":"83924_CR29","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1242\/jcs.00653","volume":"116","author":"G Maga","year":"2003","unstructured":"Maga, G. & Hubscher, U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051\u20133060. https:\/\/doi.org\/10.1242\/jcs.00653 (2003).","journal-title":"J. Cell Sci."},{"key":"83924_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081076","author":"F Luongo","year":"2019","unstructured":"Luongo, F. et al. PTEN tumor-suppressor: the dam of stemness in cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11081076 (2019).","journal-title":"Cancers (Basel)."},{"key":"83924_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12964-019-0450-3","volume":"17","author":"N Hinz","year":"2019","unstructured":"Hinz, N. & Jucker, M. Distinct functions of AKT isoforms in breast cancer: a comprehensive review. Cell Commun. Signal. 17, 154. https:\/\/doi.org\/10.1186\/s12964-019-0450-3 (2019).","journal-title":"Cell Commun. Signal."},{"key":"83924_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0299-9","author":"K Goutsouliak","year":"2019","unstructured":"Goutsouliak, K. et al. Towards personalized treatment for early stage HER2-positive breast cancer. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-019-0299-9 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"83924_CR33","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl, S. & Gianni, L. HER2-positive breast cancer. Lancet 389, 2415\u20132429. https:\/\/doi.org\/10.1016\/S0140-6736(16)32417-5 (2017).","journal-title":"Lancet"},{"key":"83924_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annonc.2019.10.007","volume":"31","author":"E Martinelli","year":"2020","unstructured":"Martinelli, E. et al. Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives. Ann. Oncol. 31, 30\u201340. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.007 (2020).","journal-title":"Ann. Oncol."},{"key":"83924_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120789","author":"TM Abu Samaan","year":"2019","unstructured":"Abu Samaan, T. M., Samec, M., Liskova, A., Kubatka, P. & Busselberg, D. Paclitaxel\u2019s mechanistic and clinical effects on breast cancer. Biomolecules. https:\/\/doi.org\/10.3390\/biom9120789 (2019).","journal-title":"Biomolecules."},{"key":"83924_CR36","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1002\/jcp.29307","volume":"235","author":"F Wang","year":"2020","unstructured":"Wang, F. et al. AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells. J. Cell Physiol. 235, 4302\u20134315. https:\/\/doi.org\/10.1002\/jcp.29307 (2020).","journal-title":"J. Cell Physiol."},{"key":"83924_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.medici.2016.03.003","volume":"52","author":"L Kursvietiene","year":"2016","unstructured":"Kursvietiene, L., Staneviciene, I., Mongirdiene, A. & Bernatoniene, J. Multiplicity of effects and health benefits of resveratrol. Medicina (Kaunas) 52, 148\u2013155. https:\/\/doi.org\/10.1016\/j.medici.2016.03.003 (2016).","journal-title":"Medicina (Kaunas)"},{"key":"83924_CR38","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/fsn3.855","volume":"6","author":"M Koushki","year":"2018","unstructured":"Koushki, M., Amiri-Dashatan, N., Ahmadi, N., Abbaszadeh, H. A. & Rezaei-Tavirani, M. Resveratrol: a miraculous natural compound for diseases treatment. Food Sci. Nutr. 6, 2473\u20132490. https:\/\/doi.org\/10.1002\/fsn3.855 (2018).","journal-title":"Food Sci. Nutr."},{"key":"83924_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111927","author":"B Xie","year":"2016","unstructured":"Xie, B. et al. Pterostilbene inhibits human multiple myeloma cells via ERK1\/2 and JNK pathway in vitro and in vivo. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms17111927 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"83924_CR40","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1158\/0008-5472.CAN-15-3541","volume":"76","author":"F Xing","year":"2016","unstructured":"Xing, F. et al. Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Cancer Res. 76, 4970\u20134980. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3541 (2016).","journal-title":"Cancer Res."},{"key":"83924_CR41","doi-asserted-by":"publisher","first-page":"382315","DOI":"10.1155\/2015\/382315","volume":"2015","author":"M Pitchaimuthu","year":"2015","unstructured":"Pitchaimuthu, M. et al. Outcome following resection of biliary cystadenoma: a single centre experience and literature review. Int. J. Hepatol. 2015, 382315. https:\/\/doi.org\/10.1155\/2015\/382315 (2015).","journal-title":"Int. J. Hepatol."},{"key":"83924_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fonc.2018.00629","volume":"8","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Long non-coding RNAs contribute to the inhibition of proliferation and EMT by pterostilbene in human breast cancer. Front. Oncol. 8, 629. https:\/\/doi.org\/10.3389\/fonc.2018.00629 (2018).","journal-title":"Front. Oncol."},{"key":"83924_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309. https:\/\/doi.org\/10.1038\/s41586-019-1730-1 (2019).","journal-title":"Nature"},{"key":"83924_CR44","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/carcin\/bgq004","volume":"31","author":"S Paul","year":"2010","unstructured":"Paul, S. et al. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin\/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis 31, 1272\u20131278. https:\/\/doi.org\/10.1093\/carcin\/bgq004 (2010).","journal-title":"Carcinogenesis"},{"key":"83924_CR45","doi-asserted-by":"publisher","first-page":"11533","DOI":"10.1021\/jf302778a","volume":"60","author":"RJ Chen","year":"2012","unstructured":"Chen, R. J. et al. Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy. J. Agric. Food Chem. 60, 11533\u201311541. https:\/\/doi.org\/10.1021\/jf302778a (2012).","journal-title":"J. Agric. Food Chem."},{"key":"83924_CR46","doi-asserted-by":"publisher","first-page":"10321","DOI":"10.1021\/acs.jafc.9b03997","volume":"67","author":"YH Hsiao","year":"2019","unstructured":"Hsiao, Y. H. et al. Pterostilbene inhibits adipocyte conditioned-medium-induced colorectal cancer cell migration through targeting FABP5-related signaling pathway. J. Agric. Food Chem. 67, 10321\u201310329. https:\/\/doi.org\/10.1021\/acs.jafc.9b03997 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"83924_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/abbs\/gmy070","volume":"50","author":"D Yu","year":"2018","unstructured":"Yu, D. et al. Targeting the PI3K\/Akt\/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression. Acta Biochim. Biophys. Sin. (Shanghai) 50, 782\u2013792. https:\/\/doi.org\/10.1093\/abbs\/gmy070 (2018).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"83924_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"83924_CR49","doi-asserted-by":"publisher","first-page":"4306579","DOI":"10.1155\/2018\/4306579","volume":"2018","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Ginsenoside Rg3 suppresses proliferation and induces apoptosis in human osteosarcoma. Biomed. Res. Int. 2018, 4306579. https:\/\/doi.org\/10.1155\/2018\/4306579 (2018).","journal-title":"Biomed. Res. Int."},{"key":"83924_CR50","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.carbpol.2013.03.009","volume":"95","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. Dipsacus asperoides polysaccharide induces apoptosis in osteosarcoma cells by modulating the PI3K\/Akt pathway. Carbohydr. Polym. 95, 780\u2013784. https:\/\/doi.org\/10.1016\/j.carbpol.2013.03.009 (2013).","journal-title":"Carbohydr. Polym."},{"key":"83924_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ptr.6227","volume":"33","author":"M Imran","year":"2019","unstructured":"Imran, M. et al. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review. Phytother. Res. 33, 263\u2013275. https:\/\/doi.org\/10.1002\/ptr.6227 (2019).","journal-title":"Phytother. Res."},{"key":"83924_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395\u2013412. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043854 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"83924_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13402-018-0410-8","volume":"42","author":"Z Zhou","year":"2019","unstructured":"Zhou, Z. et al. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K\/Akt pathway in gallbladder cancer. Cell Oncol. (Dordr) 42, 81\u201392. https:\/\/doi.org\/10.1007\/s13402-018-0410-8 (2019).","journal-title":"Cell Oncol. (Dordr)"},{"key":"83924_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biocel.2018.01.016","volume":"97","author":"YP Hu","year":"2018","unstructured":"Hu, Y. P. et al. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma. Int. J. Biochem. Cell Biol. 97, 16\u201327. https:\/\/doi.org\/10.1016\/j.biocel.2018.01.016 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"83924_CR55","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/acs.jafc.5b00002","volume":"63","author":"CH Wu","year":"2015","unstructured":"Wu, C. H., Hong, B. H., Ho, C. T. & Yen, G. C. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene. J. Agric. Food Chem. 63, 2432\u20132441. https:\/\/doi.org\/10.1021\/acs.jafc.5b00002 (2015).","journal-title":"J. Agric. Food Chem."},{"key":"83924_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2006.08.005","volume":"126","author":"K Shin","year":"2006","unstructured":"Shin, K. & Margolis, B. ZOning out tight junctions. Cell 126, 647\u2013649. https:\/\/doi.org\/10.1016\/j.cell.2006.08.005 (2006).","journal-title":"Cell"},{"key":"83924_CR57","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/s41467-017-01947-w","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Parkin targets HIF-1alpha for ubiquitination and degradation to inhibit breast tumor progression. Nat. Commun. 8, 1823. https:\/\/doi.org\/10.1038\/s41467-017-01947-w (2017).","journal-title":"Nat. Commun."},{"key":"83924_CR58","first-page":"8997","volume":"8","author":"WJ Sung","year":"2015","unstructured":"Sung, W. J. et al. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis. Int. J. Clin. Exp. Pathol. 8, 8997\u20139009 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"83924_CR59","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ijo.2015.3270","volume":"48","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells. Int. J. Oncol. 48, 595\u2013606. https:\/\/doi.org\/10.3892\/ijo.2015.3270 (2016).","journal-title":"Int. J. Oncol."},{"key":"83924_CR60","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s13277-014-2991-9","volume":"36","author":"KS Park","year":"2015","unstructured":"Park, K. S., Dubon, M. J. & Gumbiner, B. M. N-cadherin mediates the migration of MCF-10A cells undergoing bone morphogenetic protein 4-mediated epithelial mesenchymal transition. Tumour Biol. 36, 3549\u20133556. https:\/\/doi.org\/10.1007\/s13277-014-2991-9 (2015).","journal-title":"Tumour Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83924-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:08:36Z","timestamp":1670040516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83924-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83924"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83924-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4391"}}